Literature DB >> 2733040

Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women.

M A Weinstock1, G A Colditz, W C Willett, M J Stampfer, B R Bronstein, M C Mihm, F E Speizer.   

Abstract

We examined the relationship between self-reported mole counts and cutaneous melanoma with respect to anatomic site in 110 case and 231 control female nurses. Counts of moles on the lower leg were better predictors of melanoma risk than were counts of moles on the arm. The relative risk for the highest quintile of lower leg mole counts versus no lower leg moles was 4.2. Mole counts at each site (arm, thigh, and lower leg) were associated with risk of melanoma of the trunk and lower leg, but none were associated with the risk of melanoma of the upper extremity. The absence of direct site-specificity suggests that mole counts primarily indicate systemic melanoma risk, rather than direct risk from the moles themselves.

Entities:  

Mesh:

Year:  1989        PMID: 2733040     DOI: 10.1093/jnci/81.12.948

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

Review 1.  The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.

Authors:  David C Whiteman; William J Pavan; Boris C Bastian
Journal:  Pigment Cell Melanoma Res       Date:  2011-08-16       Impact factor: 4.693

2.  Cutaneous nevi and risk of melanoma death in women and men: A prospective study.

Authors:  Wen-Qing Li; Eunyoung Cho; Martin A Weinstock; Suyun Li; Meir J Stampfer; Abrar A Qureshi
Journal:  J Am Acad Dermatol       Date:  2019-01-11       Impact factor: 11.527

3.  Effect of hair color and sun sensitivity on nevus counts in white children in Colorado.

Authors:  Jenny Aalborg; Joseph G Morelli; Tim E Byers; Stefan T Mokrohisky; Lori A Crane
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

4.  Biologic markers of sun exposure and melanoma risk in women: pooled case-control analysis.

Authors:  Catherine M Olsen; Michael S Zens; Adele C Green; Therese A Stukel; C D'Arcy J Holman; Thomas Mack; J Mark Elwood; Elizabeth A Holly; Carlotta Sacerdote; Richard Gallagher; Anthony J Swerdlow; Bruce K Armstrong; Stefano Rosso; Connie Kirkpatrick; Roberto Zanetti; Julia Newton Bishop; Veronique Bataille; Yu-Mei Chang; Rona Mackie; Anne Østerlind; Marianne Berwick; Margaret R Karagas; David C Whiteman
Journal:  Int J Cancer       Date:  2010-11-16       Impact factor: 7.396

5.  Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk.

Authors:  Hongmei Nan; Mousheng Xu; Jiangwen Zhang; Mingfeng Zhang; Peter Kraft; Abrar A Qureshi; Constance Chen; Qun Guo; Frank B Hu; Eric B Rimm; Gary Curhan; Yiqing Song; Christopher I Amos; Li-E Wang; Jeffrey E Lee; Qingyi Wei; David J Hunter; Jiali Han
Journal:  Hum Mol Genet       Date:  2011-04-09       Impact factor: 6.150

6.  A prospective study of telomere length and the risk of skin cancer.

Authors:  Jiali Han; Abrar A Qureshi; Jennifer Prescott; Qun Guo; Li Ye; David J Hunter; Immaculata De Vivo
Journal:  J Invest Dermatol       Date:  2008-07-31       Impact factor: 8.551

Review 7.  Epidemiological Assessments of Skin Outcomes in the Nurses' Health Studies.

Authors:  Wen-Qing Li; Eunyoung Cho; Martin A Weinstock; Hasan Mashfiq; Abrar A Qureshi
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

8.  Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.

Authors:  Catherine M Olsen; Michael S Zens; Therese A Stukel; Carlotta Sacerdote; Yu-Mei Chang; Bruce K Armstrong; Veronique Bataille; Marianne Berwick; J Mark Elwood; Elizabeth A Holly; Connie Kirkpatrick; Thomas Mack; Julia Newton Bishop; Anne Østerlind; Anthony J Swerdlow; Roberto Zanetti; Adèle C Green; Margaret R Karagas; David C Whiteman
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.